Survival Similar in Late, Early Diagnosed Neuroendocrine Neoplasms
Patients diagnosed with neuroendocrine neoplasms during later periods did not appear to experience better overall survival compared with patients diagnosed at an earlier time. In a study of 3,431 patients, older age at diagnosis, male sex, and stage 4 disease were linked with worse survival.
Related Posts
¿Pfizer o Moderna? Una comparación directa muestra que una de las vacunas tiene una ventaja
December 2, 2021
JUEVES, 2 de diciembre de 2021 (HealthDay News) -- ¿Cuál vacuna contra el...
El rebote de la COVID no se limita a los que tomaron Paxlovid
August 4, 2022
MIÉRCOLES, 3 de agosto de 2022 (HealthDay News) -- El rebote de la COVID, que...
Health Highlights: March 14, 2022
March 14, 2022
Americans with diabetes still struggling with high insulin bills. It's a...
COVID-19 Leading Cause of Death for U.S. Children, Young People
February 6, 2023
MONDAY, Feb. 6, 2023 (HealthDay News) -- COVID-19 was a leading cause of death...
